David P. Schenkein
2016
In 2016, David P. Schenkein earned a total compensation of $3.5M as President and Chief Executive Officer at Agios Pharmaceuticals, a 65% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $340,800 |
|---|---|
| Option Awards | $2,582,051 |
| Salary | $568,000 |
| Other | $9,928 |
| Total | $3,500,779 |
Schenkein received $2.6M in option awards, accounting for 74% of the total pay in 2016.
Schenkein also received $340.8K in non-equity incentive plan, $568K in salary and $9.9K in other compensation.
Rankings
In 2016, David P. Schenkein's compensation ranked 2,636th out of 14,075 executives tracked by ExecPay. In other words, Schenkein earned more than 81.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,636 out of 14,075 | 81st |
Division Manufacturing | 903 out of 5,489 | 84th |
Major group Chemicals And Allied Products | 265 out of 1,895 | 86th |
Industry group Drugs | 192 out of 1,538 | 88th |
Industry Pharmaceutical Preparations | 145 out of 1,176 | 88th |
Source: SEC filing on April 18, 2018.
Schenkein's colleagues
We found five more compensation records of executives who worked with David P. Schenkein at Agios Pharmaceuticals in 2016.
2016
Andrew Hirsch
Agios Pharmaceuticals
Chief Financial Officer
2016
Steve Hoerter
Agios Pharmaceuticals
Chief Commercial Officer
2016
Christopher Bowden
Agios Pharmaceuticals
Chief Medical Officer
2016
Scott Biller
Agios Pharmaceuticals
Chief Scientific Officer
2016
Glenn Goddard
Agios Pharmaceuticals